Goal of Anti-infective Therapy: Reduce the invading organism to a point where the human immune response can eliminate the infection.
Action of Anti-infectives:
Bactericidal: Destroy the infective pathogen.
Bacteriostatic: Prevent the pathogen from reproducing.
Effectiveness of Anti-infectives:
Narrow Spectrum: Effective against a small group of pathogens.
Broad Spectrum: Effective against many pathogens.
Toxicities of Anti-infectives
Kidney: Some anti-infectives can cause renal dysfunction or renal failure. Monitor kidney function and urine output in patients taking nephrotoxic drugs.
GI: Very common; anti-infectives directly affect GI cells, causing nausea, vomiting, and diarrhea. The death of microorganisms can release toxins, triggering the chemoreceptor trigger zone (CTZ), causing more nausea and vomiting.
Liver: Some anti-infectives can cause hepatitis and liver failure (e.g., many cephalosporins). Monitor liver function.
Neuro: Some anti-infectives can damage nerve tissue due to accumulation in those tissues (e.g., aminoglycosides collecting in cranial nerves, causing dizziness, vertigo, or hearing loss, even hallucinations).
Allergy: Immediate or delayed allergic responses, including anaphylaxis, may occur. Monitor for a history of allergy and the type of response the patient had. Differentiate between a true allergy and a common adverse effect (e.g., N/V/D).
Superinfection: Opportunistic pathogens invade tissues that are now susceptible after healthy bacteria are wiped out by another antibiotic.
Mechanism of Action of Anti-infectives
Cell Wall Biosynthesis Interference: Some anti-infectives interfere with the biosynthesis of the pathogen cell wall (e.g., penicillins).
Essential Substance Prevention: Some anti-infectives prevent cells of the invading organism from using substances essential to growth/development, causing an inability to divide, leading to death (e.g., sulfonamides, some antimycobacterials).
Protein Synthesis Interference: Many anti-infectives interfere with steps involved in protein synthesis, which is necessary for cell division (e.g., aminoglycosides and macrolides).
DNA Synthesis Interference: Some anti-infectives interfere with DNA synthesis, impairing division leading to death (e.g., fluoroquinolones).
Cell Membrane Permeability Change: Some anti-infectives change the permeability of the cell membrane to allow leakage, leading to death (e.g., some antibiotics, antifungals, and antiprotozoals).
Penicillins
Introduction: Penicillin was the first antibiotic introduced for clinical use in the 1920s.
Development: Subsequent versions have been developed to decrease adverse effects and modify against resistant bacteria.
Resistance: Increased use of penicillin has led to more bacteria synthesizing the enzyme "penicillinase" to counteract the effects of penicillin.
Action: Bactericidal.
Unique Property: Has a beta-lactam ring in the molecular structure.
Mechanism: Interferes with the ability of bacteria to build their cell walls when dividing, which leads to swelling and bursting from pressure in the cell.
Careful administration if given IM (extremely painful).
Finish ALL the medication even if feeling better.
Use contraceptives, as antibiotics render birth control useless.
Penicillins Cross Reactivity Chart
Antibiotics that are known to be cross-reactive have a (+) in the cell.
Antibiotics with similar R1 side chains have an (X) in the cell.
Blank cells imply there is no known cross-reactivity or R1 structure similarities.
Aminoglycosides
Bactericidal - Inhibit protein synthesis
Primarily treat aerobic gram-negative bacilli
Lots of adverse effects
Crosses placenta and human milk
Synergistic bactericidal effect when given with penicillins or cephalosporins
Do not give with loop diuretics (increased ototoxicity)
Can cause bone marrow depression
Aminoglycosides Complications
Ototoxicity (SEVERE): Vestibular apparatus toxicity - hearing loss and loss of balance
Nursing Considerations: Monitor for tinnitus, headache, hearing loss, nausea, dizziness, vertigo. Do baseline hearing tests or screen for preexisting hearing loss. Educate patients to monitor for the development of hearing problems.
Nephrotoxicity (SEVERE): Acute Tubular Necrosis
Nursing Considerations: Monitor for proteinuria, urine casts, dilute urine, elevated BUN and creatinine. Monitor I/Os, BUN, creatinine. Monitor for hematuria/cloudy urine.
Intense Neuromuscular Blockade: When combined with anesthetics or NMBs – increased risk of paralysis
Nursing Considerations: Close monitoring of patients for changes with muscular strength or evidence of paralysis.
Hypersensitivity
Nursing Considerations: Monitor for rash, pruritus, paresthesia of hands/feet, urticaria.
Potential for cross-allergy with other beta-lactams
Kidney:
Can be nephrotoxic – must monitor kidney function
GI:
Commonly cause toxic GI effects. Pseudomembranous colitis, C. diff diarrhea, N/V can lead to serious dehydration and electrolyte imbalances
Superinfection
Can occur with ANY of the carbapenems. Monitor for indications of colitis (diarrhea), oral thrush, vaginal yeast infection
CNS:
HA, dizziness, altered LOC. Seizures have been reported when combined with patients taking valproic acid d/t causing subtherapeutic levels of valproic acid
Cephalosporins
Beta-lactam antibiotic – very similar to penicillins in structure and activity
Originally introduced in the 1960s, and many generations have been developed, all with different activity
Both bactericidal and bacteriostatic, depending on the dose and drug
Rule of Thumb: As the generations increase, the medication is MORE likely to:
Reach the CSF
Be LESS susceptible to beta-lactamase destruction
Be MORE effective against gram – organisms.
1st Gen: Effective against select gram-positive and select gram-negative bacteria
2nd Gen: Effective against all 1st gen bacterias + plus 3 others
3rd Gen: Effective against all 1st and 2nd gen bacterias, but less activity against gram + bacteria with more activity against gram – bacilli
4th Gen: 1 single drug. Effective against gram – and gram +
Most are excreted in the urine, but ceftriaxone is eliminated in the liver
Crosses the placenta and enters human milk
Cephalosporins Adverse Effects
Allergy
Cross-sensitivity to penicillin. Heightened monitoring in these patients
GI:
Most common including N/V/D, anorexia, abd pain, flatulence
Pseudomembranous colitis has been reported, including C. diff
CNS:
HA, dizziness, lethargy, paresthesia
Kidney:
Nephrotoxicity is possible, particularly in those with preexisting kidney dz
Increased risk of nephrotoxicity with concurrent use of aminoglycosides; monitor kidney function
Bleeding:
Do not use in patients with bleeding disorders or those using anticoagulants such as warfarin
Observe for bleeding
Monitor coagulation labs
Thrombophlebitis with IV infusion
Always dilute
Administer slowly (over 3 to 5 minutes) if bolus
Cholecystitis – with ceftriaxone
Monitor for referred left shoulder pain or abdominal tenderness
No, no, no, no alcohol
Cephalosporins Nursing Administration
Complete ALL medication
Do not combine ceftriaxone with calcium (forms precipitate)
Take oral doses with food
Store liquid suspensions in a refrigerator
Promote taking a probiotic to discourage superinfections!
Fluoroquinolones
Synthetic class
Bactericidal
Broad spectrum
Enter bacterial cell by passive diffusion through channels in the cell membrane and then interfere with the action of DNA enzymes necessary for reproduction and growth = cell death
Gram + and gram –
Therapeutic uses: urinary, respiratory, skin infections, and prevention/treatment of anthrax
Metabolized in the liver, excreted in urine and feces
Crosses placenta and enters human milk
This class has many boxed warnings d/t potential serious adverse effects
Not recommended for the treatment of uncomplicated infections
Fluoroquinolones Adverse Effects
Common:
HA, dizziness, insomnia, depression d/t CNS effects
GI effects include N/V/D, dry mouth, possibly d/t CTZ stimulation
More Serious:
Tendinitis, tendon rupture
Achilles tendon rupture (specifically, however, can also cause extreme muscle pain, joint and nerve pain, and other nervous system disturbances)
Risk increases when fluoroquinolones are combined with corticosteroids
Evaluate for pain, swelling, tenderness, redness near the Achilles tendon
Tell patients to stop the medication and avoid any exercise, and notify the provider
Peripheral neuropathy, CNS effects
Cardiac:
Prolonged QT interval, palpitations, and dysrhythmias
C. diff – Increased risk with Cipro
Superinfection – thrush, vaginal yeast infection
Immunological:
Bone marrow depression (likely d/t drug effects on cells of the bone marrow)
Other:
Severe Phototoxicity – even with sunscreen
Fever, rash, and other severe skin reactions
Contraindications
Do not administer to children under 18 d/t increased risk of Achilles tendon rupture unless treatment is for E. coli UTI or anthrax
Fluoroquinolones Interactions
Minerals
Avoid calcium, aluminum-magnesium antacids, iron salts, sucralfate, dairy
Separate doses by 4 hours if necessary
Cardiac:
If taken with any other drugs that increase the QT interval, severe to fatal cardiac reactions are possible
Bleeding:
Increased plasma levels of warfarin
Monitor INR and for signs of bleeding
CNS
NSAIDS with fluoroquinolones increase the risk of CNS stimulation
Monitor for SZ, dizziness, HA
Fluoroquinolones Nursing Administration
Educate patients to immediately report joint/tendon pain or CNS disturbances like psychosis and confusion
Sulfonamides (Sulfa)
Inhibit folic acid synthesis (precursors of RNA and DNA)
Effective against gram – and gram +
Therapeutic Uses
UTIs typically caused by E. coli
Chlamydia trachomatis
Nocardia
H. flu
E. coli
P. mirabilis
Passes into human milk
HIGHLY TERATOGENIC
Metabolized in the liver and excreted in urine
Sulfonamides Contraindications
Allergy to sulfonamides, sulfonylureas, thiazide or loop diuretics (cross-sensitivity)
Pregnancy (kernicterus – see below)
Lactation (kernicterus, diarrhea, rash in the infant)
Folate deficiency (increased risk of megaloblastic anemia)
Kidney DZ or kidney stones (give lower dose)
Cautious use for patients >65 d/t increased risk of thrombocytopenia, hyperkalemia, folate deficiency
Cautious use in patients who take ACEI or ARBs or potassium-sparing diuretics d/t increased risk of hyperkalemia
Patients taking antidiabetic agents concurrently have an increased risk of hypoglycemia (must reduce dose of antidiabetic drug)
Sulfonamides Adverse Effects
GI
N/V/D, abd pain, anorexia, stomatitis, hepatic injury
Kidney
Crystalluria – collection of crystalline in the kidneys/ureters/bladder causing irritation/obstruction developing into AKI
Hematuria, hyperkalemia, proteinuria ---> can progress to nephrotic syndrome and toxic nephrosis
Nursing Consideration
Encourage at least 8 – 8oz glasses of water each day
Monitor urine output (minimum 1200ml/day)
CNS
HA, dizziness, vertigo, ataxia, convulsions, depression